argus

Emcure Pharmaceuticals Limited

NSE: EMCUREINE168P0101534,979 Cr

Timeline

Time (IST)TypeMEventSrc
05 May, 03:04 pmEmcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Change in Managementbse
05 May, 02:49 pmEmcure Pharmaceuticals Limited has informed the Exchange about Investor Presentationnse
05 May, 02:47 pmEmcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
05 May, 02:33 pmEmcure Pharmaceuticals Ltd - 544210 - Corporate Action-Board approves Dividendbse
05 May, 02:31 pmEmcure Pharmaceuticals Ltd - 544210 - Financial Results (Standalone And Consolidated) For The Quarter And Year Ended March 31, 2026bse
05 May, 02:21 pmRecommendation of Final Dividend for the Financial Year 2025-26nse
05 May, 02:05 pmOutcome of the Board Meeting held on May 05, 2026.nse
28 Apr, 07:00 pmEmcure Pharmaceuticals Ltd - 544210 - Board Meeting Intimation for Approval Of Audited Financial Results (Standalone And Consolidated) For The Quarter And Year Ended March 31, 2026bse
27 Apr, 08:28 pmEmcure Pharmaceuticals Ltd - 544210 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Update On Appointment Of Independent Directorbse
27 Apr, 08:23 pmEmcure Pharmaceuticals Limited has informed the Exchange about General Updatesnse
02 Apr, 03:24 pmEmcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
02 Apr, 03:23 pmEmcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 02, 2026, titled "Emcure Pharma Reduces Poviztra® Starting Dose Price by 55% to Expand Patient Access".nse
01 Apr, 09:46 pmEmcure Pharmaceuticals Limited has informed the Exchange about Acquisitionnse
01 Apr, 09:40 pmEmcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Acquisitionbse
24 Mar, 02:13 pmEmcure Pharmaceuticals Ltd - 544210 - Update On Re-Appointment Of Independent Directorsbse
24 Mar, 02:11 pmEmcure Pharmaceuticals Limited has informed the Exchange about General Updatesnse
10 Mar, 01:24 pmEmcure Pharmaceuticals Ltd - 544210 - Clarification On Volume Movement Letterbse
10 Mar, 11:42 amEmcure Pharmaceuticals Ltd - 544210 - Clarification sought from Emcure Pharmaceuticals Ltdbse
09 Mar, 01:29 pmEmcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Change in Managementbse
09 Mar, 01:29 pmEmcure Pharmaceuticals Limited has informed the Exchange about change in Managementnse
09 Mar, 01:08 pmEmcure Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on March 09, 2026.nse
03 Mar, 06:49 pmEmcure Pharmaceuticals Limited has informed the Exchange regarding allotment of 17000 securities pursuant to ESOP/ESPS at its meeting held on March 03, 2026nse
02 Mar, 02:49 pmEmcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 02, 2026, titled "Press Release titled Emcure Pharmaceuticals and Roche Sign Distribution Agreement to Strengthen Nephrology and Transplant Care in India ".nse
02 Mar, 02:47 pmEmcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
20 Feb, 06:27 pmEmcure Pharmaceuticals Limited has informed the Exchange about Investor Presentationnse
20 Feb, 06:24 pmEmcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
10 Feb, 06:05 pmEmcure Pharmaceuticals Limited has informed the Exchange about Transcriptnse
10 Feb, 06:00 pmEmcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
07 Feb, 09:57 pmEmcure Pharmaceuticals Ltd - 544210 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') - Incident Of Fire At Our Manufacturing Plant Located At Hinjawadi, Pune, Maharashtrabse
07 Feb, 09:56 pmEmcure Pharmaceuticals Limited has informed the Exchange regarding 'Incident of fire at our manufacturing plant located at Hinjawadi, Pune, Maharashtra'.nse
04 Feb, 06:40 pmEmcure Pharmaceuticals Limited has informed the Exchange about Link of Recordingnse
04 Feb, 06:35 pmEmcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
04 Feb, 03:07 pmEmcure Pharmaceuticals Ltd - 544210 - Disclosure Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
04 Feb, 03:06 pmEmcure Pharmaceuticals Limited has informed the Exchange about General Updatesnse
04 Feb, 02:29 pmEmcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Change in Managementbse
04 Feb, 02:22 pmEmcure Pharmaceuticals Limited has informed the Exchange about change in Managementnse
04 Feb, 02:08 pmEmcure Pharmaceuticals Ltd - 544210 - Appointment of Company Secretary and Compliance Officerbse
04 Feb, 02:08 pmEmcure Pharmaceuticals Limited has informed the Exchange about Change in Company Secretary/Compliance Officernse
04 Feb, 01:40 pmEmcure Pharmaceuticals Ltd - 544210 - Unaudited Financial Results (Consolidated And Standalone) For The Quarter And Nine Months Ended December 31, 2025.bse
04 Feb, 01:34 pmEmcure Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.nse
04 Feb, 01:32 pmEmcure Pharmaceuticals Ltd - 544210 - Board Meeting Outcome for Outcome Of Board Meeting Held On February 04, 2026.bse
22 Jan, 04:05 pmEmcure Pharmaceuticals Ltd - 544210 - Board Meeting Intimation for Board Meeting Intimation For Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31, 2025bse
23 Dec, 06:12 pmEmcure Pharmaceuticals Limited has informed the Exchange about General Updatesnse
23 Dec, 06:11 pmEmcure Pharmaceuticals Ltd - 544210 - Update On US FDA Inspection At Our Manufacturing Facility Located At Kadu, Surendranagar, Gujarat, India.bse
22 Dec, 11:41 amEmcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 22, 2025, titled "Press Release titled Emcure Expands Weight Management Therapy Access with Launch of Poviztra® .".nse
22 Dec, 11:40 amEmcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
16 Dec, 10:09 pmEmcure Pharmaceuticals Limited has informed the Exchange regarding allotment of 7700 securities pursuant to ESOP/ESPS at its meeting held on December 16, 2025nse
27 Nov, 04:38 pmEmcure Pharmaceuticals Ltd - 544210 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Regarding Search And Seizure/ Inspection Operation Conducted By The Goods & Service Tax Department, Mumbai, Maharashtra.bse
27 Nov, 04:26 pmEmcure Pharmaceuticals Limited has informed the Exchange about Action(s) initiated or orders passednse
21 Nov, 05:57 pmEmcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officerbse